AzTrials
AzTrials

Idiopathic Pulmonary FibrosisPhase 3FIBRONEER™-ONNCT06238622

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

A Phase 3 study testing Nerandomilast in people with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis, run by Boehringer Ingelheim at 374 sites in 44 countries.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Nerandomilast
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,666 participants
Where
374 sitesin 44 countries
Study dates
26 Sep 2024to 7 May 2027
Phase
Phase 3

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients who completed treatment in the parent trials (1305-0014, 1305-0023, or 1305-0035) without prematurely discontinuing treatment permanently according to protocol (i.e. completed treatment with or without temporary treatment interruption)
  • Signed and dated written informed consent in accordance with ICH-GCP and local legislation prior to admission to the trial
  • Women of childbearing potential (WOCBP) must be ready and able to use highly effective methods of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly. WOCBP taking oral contraceptives (OCs) also have to ensure the use of one barrier method during sexual intercourse with their partner, e.g., condom to account for the risk of potentially reduced efficacy of the OCs in the event of severe vomiting and diarrhoea. For France, fertile males must be ready and able to use acceptable methods of birth control

Who cannot join

  • Any disease that may put the patient at risk when participating in this trial at investigator's discretion.
  • Patient exhibits suicidality, in the clinical judgment of the investigator or according to the following criteria at Visit 1:
  • any suicidal behaviour (i.e. actual attempt, interrupted attempt, aborted attempt, or preparatory acts or behaviour)
  • any suicidal ideation of type 4 or 5 in the Columbia-Suicide Severity Rating Scale (C-SSRS) (i.e. active suicidal thought with intent but without specific plan, or active suicidal thought with plan and intent)
  • Patients with clinically relevant severe depression at investigator's discretion or a Hospital Anxiety and Depression Scale (HADS) subscore >14 at Visit 1.
  • An occurrence of malignant neoplasm other than appropriately treated basal cell carcinoma or in situ squamous cell carcinoma of the skin or in situ carcinoma of uterine cervix at Visit 1.
Show all 11Show fewer
  • Patient will undergo lung transplantation, with an assigned date of surgery.
  • Patients with a Body Mass index (BMI) <18.5 kg/m² that experienced an additional, unexplained and clinically significant (>10%) weight loss during the parent trial
  • At Visit 1, patients with ongoing Adverse Event of Special Interest (AESI), except for latent tuberculosis (suspected vasculitis, Drug Induced Liver Injury (DILI), severe infections) that led to temporary treatment interruption in the parent trial
  • Patients who must or wish to take restricted medications or any drug considered likely to interfere with the safe conduct of the trial.
  • Further exclusion criteria apply.

Trial locations and contacts

374 sites in 44 countries.

374 sites in 44 countries

United States58 sites
  • University of Michigan

    Ann Arbor, Michigan, 48109

  • Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead

    Atlanta, Georgia, 30309

  • The Emory Clinic

    Atlanta, Georgia, 30322

  • Johns Hopkins Hospital

    Baltimore, Maryland, 21224

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115

  • St. Elizabeth's Medical Center

    Boston, Massachusetts, 02135

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215

  • University of Vermont

    Burlington, Vermont, 05401

  • Lowcountry Lung and Critical Care

    Charleston, South Carolina, 29406

  • The Lung Research Center, LLC

    Chesterfield, Missouri, 63017

  • University of Cincinnati

    Cincinnati, Ohio, 45267

  • St. Francis Medical Institute

    Clearwater, Florida, 33765

  • Cleveland Clinic

    Cleveland, Ohio, 44195

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio, 43210

  • Baylor University Medical Center

    Dallas, Texas, 75246

  • National Jewish Health

    Denver, Colorado, 80206

  • Duke University Medical Center

    Durham, North Carolina, 27710

  • Infinity Medical Research, Inc.

    East Providence, Rhode Island, 02914

  • Northshore University Health System

    Evanston, Illinois, 60201

  • Inova Fairfax Hospital

    Falls Church, Virginia, 22042

  • Clinical Trials Center of Middle Tennessee, LLC

    Franklin, Tennessee, 37067

  • University of Florida

    Gainesville, Florida, 32610

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

  • Clinical Research Specialists LLC - Kissimmee

    Kissimmee, Florida, 34746

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, 03756

  • University of Southern California

    Los Angeles, California, 90033

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048

  • University of California Los Angeles

    Los Angeles, California, 90095

  • Advanced Pulmonary Research Institute

    Loxahatchee Groves, Florida, 33470

  • University of Wisconsin

    Madison, Wisconsin, 53792

  • University of Minnesota

    Minneapolis, Minnesota, 55455

  • Northern Westchester Hospital

    Mount Kisco, New York, 10549

  • Intermountain Medical Center-Murray-69497

    Murray, Utah, 84107

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37204

  • Yale University School of Medicine

    New Haven, Connecticut, 06510

  • Tulane Medical Center

    New Orleans, Louisiana, 70112

  • Columbia University Medical Center-New York Presbyterian Hospital

    New York, New York, 10032

  • NewYork-Presbyterian/Weill Cornell Medical Center

    New York, New York, 10065

  • Christiana Hospital

    Newark, Delaware, 19713

  • Creighton University

    Omaha, Nebraska, 68124

  • University of Nebraska Medical Center

    Omaha, Nebraska, 68198

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104

  • Temple University

    Philadelphia, Pennsylvania, 19140

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania, 15212

  • The Oregon Clinic

    Portland, Oregon, 97220

  • Renown Regional Medical Center

    Reno, Nevada, 89502

  • Mayo Clinic, Rochester

    Rochester, Minnesota, 55905

  • Corewell Health William Beaumont University Hospital

    Royal Oak, Michigan, 48073

  • University of California Davis

    Sacramento, California, 95817

  • University of Utah Health Sciences Center

    Salt Lake City, Utah, 84108

  • UT Health San Antonio

    San Antonio, Texas, 78229

  • Virginia Mason Medical Center

    Seattle, Washington, 98101

  • Renovatio Clinical-The Woodlands-69551

    The Woodlands, Texas, 77380

  • University of Arizona

    Tucson, Arizona, 85724

  • Georgetown University

    Washington D.C., District of Columbia, 20007

  • Southeastern Research Center-Winston Salem-69289

    Winston-Salem, North Carolina, 27103

Other trials in United States

Japan38 sites
  • Tosei General Hospital

    Aichi, Seto, 489-8642

  • Chiba University Hospital

    Chiba, Chiba, 260-8677

  • University of Fukui Hospital

    Fukui, Yoshida-gun, 910-1193

  • National Hospital Organization Kyushu Medical Center

    Fukuoka, Fukuoka, 810-8563

  • Kyushu University Hospital

    Fukuoka, Fukuoka, 812-8582

  • Aso Co.,Ltd Iizuka Hospital

    Fukuoka, Iizuka, 820-8505

  • Hospital of the University of Occupational and Environmental Health

    Fukuoka, Kitakyushu, 807-8556

  • Kurume University Hospital

    Fukuoka, Kurume, 830-0011

  • Fukushima Medical University Hospital

    Fukushima, Fukushima, 960-1295

  • Tsuboi Hospital

    Fukushima, Koriyama, 963-0197

  • Hiroshima Prefectural Hospital

    Hiroshima, Hiroshima, 734-8530

  • Sapporo Medical University Hospital

    Hokkaido, Sapporo, 060-8543

  • Hokkaido University Hospital

    Hokkaido, Sapporo, 060-8648

  • National Hospital Organization Himeji Medical Center

    Hyogo, Himeji, 670-8520

  • Kobe City Medical Center General Hospital

    Hyogo, Kobe, 650-0047

  • Kobe City Hospital Organization Kobe City Medical Center West Hospital

    Hyogo, Kobe, 653-0013

  • Kagawa University Hospital

    Kagawa, Kita-gun, 761-0793

  • Kanagawa Cardiovascular and Respiratory Center

    Kanagawa, Yokohama, 236-0051

  • Saiseikai Kumamoto Hospital

    Kumamoto, Kumamoto, 861-4193

  • Tohoku University Hospital

    Miyagi, Sendai, 980-8574

  • Nagasaki University Hospital

    Nagasaki, Nagasaki, 852-8501

  • Kindai University Hospital

    Osaka, Sakai, 590-0197

  • National Hospital Organization Kinki-Chuo Chest Medical Center

    Osaka, Sakai, 591-8555

  • Osaka Medical and Pharmaceutical University Hospital

    Osaka, Takatsuki, 569-8686

  • Saitama Red Cross Hospital

    Saitama, Saitama, 330-8553

  • Shimane University Hospital

    Shimane, Izumo, 693-8501

  • Hamamatsu University Hospital

    Shizuoka, Hamamatsu, 431-3192

  • Jichi Medical University Hospital

    Tochigi, Shimotsuke, 329-0498

  • Tokushima University Hospital

    Tokushima, Tokushima, 770-8503

  • Juntendo University Hospital

    Tokyo, Bunkyo-ku, 113-8431

  • Nippon Medical School Hospital

    Tokyo, Bunkyo-ku, 113-8603

  • Toranomon Hospital

    Tokyo, Minato-ku, 105-8470

  • Kyorin University Hospital

    Tokyo, Mitaka, 181-8611

  • Toho University Omori Medical Center

    Tokyo, Ota-ku, 143-8541

  • Tokyo Medical University Hospital

    Tokyo, Shinjuku-ku, 160-0023

  • Keio University Hospital

    Tokyo, Shinjuku-ku, 160-8582

  • National Center for Global Health and Medicine

    Tokyo, Shinjuku-ku, 162-8655

  • Wakayama Medical University Hospital

    Wakayama, Wakayama, 641-8510

Other trials in Japan

China37 sites
  • Beijing Chao-Yang Hospital

    Beijing, 100020

  • China-Japan Friendship Hospital

    Beijing, 100029

  • Peking Union Medical College Hospital

    Beijing, 100730

  • The Second Xiangya Hospital Of Central South University

    Changsha, 410011

  • West China Hospital, Sichuan University

    Chengdu, 610041

  • Sichuan Provincial People's Hospital

    Chengdu, 610072

  • First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, 510120

  • NanFang Hosptial

    Guangzhou, 510515

  • Hangzhou First People's Hospital

    Hangzhou, 310006

  • The Second Affiliated Hospital Zhejiang University School of Medicine

    Hangzhou, 310009

  • Zhejiang Hospital

    Hangzhou, 310013

  • Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine

    Hangzhou, 310016

  • Anhui Provincial Hospital

    Hefei, 230001

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, 010000

  • The First Hospital of Jiaxing

    Jiaxing, 314000

  • Jinhua Municipal Central Hospital

    Jinhua, 321000

  • Nanjing Drum Tower Hospital

    Nanjing, 210008

  • Ningbo Medical Center Lihuili Hospital

    Ningbo, 315000

  • The First Affiliated Hospital of Ningbo University

    Ningbo, 315010

  • Ruijin Hospital Shanghai Jiao Tong University School of Medicine

    Shanghai, 200025

  • Shanghai Chest Hospital

    Shanghai, 200030

  • Zhongshan Hospital Affiliated to Fudan University

    Shanghai, 200032

  • Huadong Hospital affiliated to Fudan University

    Shanghai, 200040

  • China Shenyang Chest Hospital

    Shenyang, 110000

  • Shenzhen People's Hospital

    Shenzhen, 518020

  • The University of Hong Kong-Shenzhen Hospital

    Shenzhen, 518053

  • The First Affiliated Hospital of Soochow University

    Suzhou, 215006

  • Tianjin Medical University General Hospital

    Tianjin, 30052

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, 325000

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, 430022

  • Tongji Hospital Affiliated Tongji Medical College Huazhong University of S & T

    Wuhan, 430030

  • Renmin Hospital of Wuhan University

    Wuhan, 430060

  • Wuxi People's Hospital

    Wuxi, 214043

  • Second Affiliated Hospital of medical college of Xi'an JiaoTong University

    Xi'an, 710004

  • The Affiliated Hospital of Xuzhou Medical College

    Xuzhou, 221009

  • Yichang Central People's Hospital

    Yichang, 443000

  • General Hospital of Ningxia Medical University

    Yinchuan, 750004

Other trials in China

Spain23 sites
  • Hospital General Universitario de Alicante

    Alicante, 03010

  • Hospital del Mar

    Barcelona, 08003

  • Hospital Universitari Vall d'Hebron

    Barcelona, 08035

  • Hospital Clínic de Barcelona

    Barcelona, 08036

  • Hospital de Basurto

    Bilbao, 48013

  • Hospital Universitario Virgen de la Arrixaca

    El Palmar, 30120

  • Hospital de Galdakao

    Galdakao, 48960

  • Hospital Universitario Virgen de las Nieves

    Granada, 18014

  • Hospital Universitari de Bellvitge

    L'Hospitalet de Llobregat, 08907

  • Hospital Universitario De La Princesa

    Madrid, 28006

  • Hospital General Universitario Gregorio Marañón

    Madrid, 28007

  • Hospital Universitario Infanta Leonor

    Madrid, 28031

  • Hospital Universitario Ramon Y Cajal

    Madrid, 28034

  • Hospital Universitario 12 de Octubre

    Madrid, 28041

  • Hospital Universitario Virgen de la Victoria

    Málaga, 29010

  • Hospital Central de Asturias

    Oviedo, 33011

  • Hospital Son Espases

    Palma de Mallorca, 07120

  • Hospital Quirónsalud Madrid

    Pozuelo de Alarcón, 28223

  • Hospital Universitario Marqués de Valdecilla

    Santander, 39008

  • Hospital Clínico de Santiago

    Santiago de Compostela, 15706

  • Hospital Virgen del Rocio

    Seville, 41013

  • Hospital Nuestra Señora de Valme

    Seville, 41014

  • Hospital General Universitario de Valencia

    Valencia, 46014

Other trials in Spain

France21 sites
  • HOP d'Angers

    Angers, 49933

  • HOP Avicenne

    Bobigny, 93000

  • HOP de la Cavale Blanche

    Brest, 29200

  • Hopital Louis Pradel

    Bron, 69677

  • HOP CHU Caen

    Caen, 14033

  • HOP François Mitterrand

    Dijon, 21000

  • HOP Michallon

    La Tronche, 38700

  • HOP Bicêtre

    Le Kremlin-Bicêtre, 94275

  • INS Coeur Poumon

    Lille, 59037

  • HOP Nord

    Marseille, 13915

  • HOP Nord Laennec

    Nantes, 44093

  • Hopital Pasteur

    Nice, 06001

  • HOP Paris Saint-Joseph

    Paris, 75014

  • HOP Européen G. Pompidou

    Paris, 75015

  • HOP Bichat

    Paris, 75877

  • HOP Haut-Lévêque

    Pessac, 33604

  • HOP Robert Debré

    Reims, 51100

  • HOP Pontchaillou

    Rennes, 35033

  • Hôpital Charles Nicolle

    Rouen, 76031

  • HOP Foch

    Suresnes, 92151

  • Hôpital Larrey - CHU de Toulouse

    Toulouse, 31059

Other trials in France

Germany19 sites
  • Velocity Clinical Research Germany GmbH, Ahrensburg

    Ahrensburg, 22926

  • CIMS Studienzentrum Bamberg GmbH

    Bamberg, 96049

  • Vivantes Netzwerk für Gesundheit GmbH

    Berlin, 12351

  • Universitätsklinikum Bonn AöR

    Bonn, 53127

  • Fachkrankenhaus Coswig GmbH

    Coswig, 01640

  • Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen gGmbH

    Essen, 45239

  • Universitätsklinikum Hamburg, Eppendorf

    Hamburg, 20246

  • Klinikum Region Hannover GmbH

    Hanover, 30459

  • Medizinische Hochschule Hannover

    Hanover, 30625

  • Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg

    Heidelberg, 69126

  • Lungenklinik Hemer

    Hemer, 58675

  • Lungenfachklinik Immenhausen

    Immenhausen, 34376

  • Klinikum Konstanz

    Konstanz, 78464

  • Klinikum der Universität München AÖR

    München, 81377

  • Klinikum Nürnberg

    Nuremberg, 90419

  • Krankenhaus Bethanien gGmbH

    Solingen, 42699

  • Helios Hanseklinikum Stralsund

    Stralsund, 18435

  • Robert Bosch Gesellschaft für medizinische Forschung mbH

    Stuttgart, 70376

  • Universitätsklinikum Tübingen

    Tübingen, 72076

Other trials in Germany

Canada13 sites
  • University of Alberta Hospital (University of Alberta)

    Edmonton, Alberta, T6G 1Z1

  • QEII Health Sciences Centre

    Halifax, Nova Scotia, B3H 3A7

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, L8N 1Y2

  • Kelowna Respirology & Allergy Research

    Kelowna, British Columbia, V1Y 3H5

  • Dr. Georges-L.-Dumont University Hospital Centre

    Moncton, New Brunswick, E1C 2Z3

  • Centre Hospitalier de l'Universite de Montreal (CHUM)

    Montreal, Quebec, H2X 0C1

  • McGill University Health Centre (MUHC)

    Montreal, Quebec, H4A 3J1

  • Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ)

    Québec, G1V 4G5

  • Royal University Hospital (Saskatoon)

    Saskatoon, Saskatchewan, S7N 0W8

  • CIC Mauricie (Trois Rivieres)

    Trois-Rivières, Quebec, G8T 7A1

  • St. Paul's Hospital (Vancouver)

    Vancouver, British Columbia, V1Y 1S1

  • Vancouver General Hospital

    Vancouver, British Columbia, V5Z 1M9

  • Dr. Syed Anees Medicine Professional Corporation

    Windsor, Ontario, N8X 1T3

Other trials in Canada

Italy13 sites
  • ASST degli Spedali Civili di Brescia

    Brescia, 25123

  • A.O.U. Policlinico Vittorio Emanuele

    Catania, 95124

  • A. O. Universitaria Careggi

    Florence, 50137

  • Ospedale Colonnello D Avanzo

    Foggia, 71100

  • Ospedale G.B. Morgagni

    Forlì, 47121

  • Ospedale San Paolo-MILANO-18793

    Milan, 20100

  • Ospedale Classificato San Giuseppe

    Milan, 20123

  • Azienda Ospedaliero-Universitaria di Modena

    Modena, 41100

  • A.O. San Gerardo di Monza

    Monza, 20052

  • Azienda Ospedaliera Universitaria di Padova

    Padova, 35128

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, 00168

  • A.O.U. Senese

    Siena, 53100

  • Ospedali Riuniti di Ancona

    Torrette Di Ancona (Ancona), 60126

Other trials in Italy

United Kingdom13 sites
  • Aberdeen Royal Infirmary

    Aberdeen, AB25 2ZN

  • Queen Elizabeth Hospital Birmingham

    Birmingham, B15 2GW

  • Southmead Hospital

    Bristol, BS10 5NB

  • Royal Infirmary of Edinburgh

    Edinburgh, EH16 4SA

  • Royal Devon and Exeter Hospital, Wonford

    Exeter, EX2 5DW

  • Royal Lancaster Infirmary

    Lancaster, LA1 4RP

  • St James's University Hospital

    Leeds, LS9 7TF

  • Guy's Hospital

    London, SE1 9RT

  • Royal Brompton Hospital

    London, SW3 6NP

  • Altnagelvin Area Hospital

    Londonderry, BT47 6SB

  • Wythenshawe Hospital

    Manchester, M23 9QZ

  • Churchill Hospital

    Oxford, OX3 7LE

  • Southampton General Hospital

    Southampton, SO16 6YD

Other trials in United Kingdom

Australia11 sites
  • Royal Adelaide Hospital

    Adelaide, South Australia, 5000

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, 2050

  • Lung Research Queensland

    Chermside, Queensland, 4032

  • The Prince Charles Hospital

    Chermside, Queensland, 4032

  • Canberra Hospital

    Garran, Australian Capital Territory, 2605

  • Austin Hospital

    Heidelberg, Victoria, 3084

  • Macquarie University

    Macquarie Park, 2109

  • The Alfred Hospital

    Melbourne, Victoria, 3004

  • Fiona Stanley Hospital

    Murdoch, Western Australia, 6150

  • Trialswest

    Spearwood, Western Australia, 6163

  • Westmead Hospital

    Westmead, New South Wales, 2145

Other trials in Australia

Argentina9 sites
  • Centro de Investigaciones Metabolicas (CINME)

    C.a.b.a, 1056

  • Fundacion NIBA Neurologia Infantil Buenos Aires

    CABA, 1182

  • Hospital Italiano de Buenos Aires

    CABA, C1199ABD

  • Consultorios Medicos del Buen Ayre

    Capital Federal, 1425

  • CEMER-Centro Medico De Enfermedades Respiratorias

    Florida, B1602DQD

  • Instituto Ave Pulmo - Fundacion Enfisema

    Mar del Plata, 7600

  • INSARES

    Mendoza, M5500CCG

  • Centro Respiratorio de Quilmes

    Quilmes, B1878FNR

  • Instituto Medico de la Fundacion Estudios Clinicos

    Rosario, S2000DEJ

Other trials in Argentina

Brazil9 sites
  • Serviços Medicos Respirar Sul Fluminense

    Barra Mansa, 27323240

  • Hospital das Clinicas da Universidade Federal de Minas Gerais (HC-UFMG)

    Belo Horizonte,Minas Gerais, 31270901

  • SAPIENS - Instituto de Estudos e Pesquisa Clinica

    Curitiba, 80810-000

  • CLARE - Clinica de Pneumologia

    Goiânia, 74110-030

  • Irmandade Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, 90020-090

  • Hospital Nossa Senhora da Conceição

    Porto Alegre - RS, 91350-250

  • CEMEC - Centro Multidisciplinar de Estudos Clínicos

    São Bernardo do Campo, 09715-090

  • Hospital Alemao Oswaldo Cruz

    São Paulo, 01327-001

  • Hospital das Clinicas da Faculdade de Medicina da USP

    São Paulo, 05403-000

Other trials in Brazil

South Korea8 sites
  • The Catholic University of Korea, Bucheon St.Mary's Hospital

    Bucheon-si, 14647

  • Seoul National University Bundang Hospital

    Seongnam, 13620

  • Kyung Hee University Hospital

    Seoul, 02447

  • Seoul National University Hospital

    Seoul, 03080

  • Severance Hospital

    Seoul, 03722

  • Soonchunhyang University Hospital Seoul

    Seoul, 04401

  • Asan Medical Center

    Seoul, 05505

  • Samsung Medical Center

    Seoul, 135-710

Other trials in South Korea

Belgium7 sites
  • Ziekenhuis Netwerk Antwerpen (ZNA) - Campus Middelheim

    Antwerp, 2020

  • Hopital Erasme

    Brussels, 1070

  • Cliniques Universitaires Saint-Luc

    Brussels, 1200

  • Universitair Ziekenhuis Gent

    Ghent, 9000

  • UZ Leuven

    Leuven, 3000

  • Centre Hospitalier Universitaire de Liège

    Liège, 4000

  • Yvoir - UNIV UCL de Mont-Godinne

    Yvoir, 5530

Other trials in Belgium

Mexico7 sites
  • Centro de Investigacion Integral MEDIVEST S.C

    Chihuahua City, 31203

  • CREPID Aire y Salud Integral

    Coyoacán, 04380

  • Centro de Investigacion Farmacologica del Bajío, S.C.

    León, 37160

  • Soltmed Smo

    Mexico City, 03650

  • Centro Respiratorio de Mexico

    Mexico City, 14050

  • Centro de Prevención y Rehabilitación de Enfermedades Pulmon

    Monterrey, 64460

  • Oaxaca Site Management Organization, S.C.

    Oaxaca City, 68000

Other trials in Mexico

Taiwan7 sites
  • Changhua Christian Hospital

    Changhua, 500

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, 807

  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 83301

  • Taichung Veterans General Hospital

    Taichung, 407

  • NCKUH

    Tainan, 704

  • National Taiwan University Hospital

    Taipei, 100

  • Taipei Veterans General Hospital

    Taipei, 11217

Other trials in Taiwan

Austria6 sites
  • Krems University Hospital

    Krems, 3500

  • LKH Salzburg University Hospital

    Salzburg, 5020

  • Medical University of Vienna

    Vienna, 1090

  • Standort Penzing der Klinik Ottakring

    Vienna, 1140

  • Clinic Floridsdorf

    Vienna, 1210

  • Klinikum Wels - Grieskirchen GmbH

    Wels, 4600

Other trials in Austria

Poland5 sites
  • Uniwersyteckie Centrum Kliniczne

    Gdansk, 80-214

  • Leszek Giec Upper-Silesian Med.Cent.Silesian Med.Univ.

    Katowice, 40-635

  • Przychodnia Alergologiczno-Pulmonologiczna Alergopneuma Sp. z o.o.

    Świdnik, 21 040

  • Nat.Instit.of Tuberculosis&LungDiseases,Outpat.Clin,warszawa

    Warsaw, 01-138

  • University Clinical Center of the Medical University of Warsaw

    Warsaw, 02097

Other trials in Poland

Portugal5 sites
  • ULS de Braga, E.P.E

    Braga, 4710-243

  • CHUC - Centro Hospitalar e Universitario de Coimbra, EPE

    Coimbra, 3004-561

  • ULS de São José, E.P.E.

    Lisbon, 1169-024

  • USLM, EPE - Hospital Pedro Hispano

    Matosinhos Municipality, 4454-509

  • Centro Hospitalar Vila Nova de Gaia/Espinho, E.P.E

    Vila Nova de Gaia, 4434-502

Other trials in Portugal

Thailand5 sites
  • Siriraj Hospital

    Bangkok Noi, 10700

  • Srinagarind Hospital

    Khon Kaen, 40002

  • Maharat Nakhonchiangmai Hospital

    Muang, 50200

  • Ramathibodi Hospital

    Ratchatewi, 10400

  • Songklanagarind Hospital

    Songkhla, 90110

Other trials in Thailand

Turkey (Türkiye)5 sites
  • Gulhane Training and Research Hospital

    Ankara, 06010

  • Ankara Universitesi Tip Fakultesi

    Ankara, 06620

  • Akdeniz Universitesi Tip Fakultesi -ANTALYA-33606

    Antalya, 07070

  • Istanbul Universitesi Istanbul Tip Fakultesi

    Çapa, 34390

  • Gazi Universitesi Tip Fakultesi

    Yenimahalle/ANKARA, 06560

Other trials in Turkey (Türkiye)

Finland4 sites
  • HYKS Keuhkosairauksien tutkimusyksikkö

    Helsinki, 00029

  • Oulun yliopistollinen keskussairaala

    Oulu, 90220

  • Tampere University Hospital

    Tampere, 33520

  • TYKS

    Turku, 20520

Other trials in Finland

Greece4 sites
  • Hospital of Heraklion (PAGNI)

    Heraklion, 71110

  • Univ. Gen. Hosp. of Ioannina

    Ioannina, 45 500

  • Univ. Gen. Hosp. of Patras

    Pátrai, 26504

  • General Hospital of Thessaloniki "Hippokrateio"

    Thessaloniki, 546 42

Other trials in Greece

Israel4 sites
  • Shamir Medical Center (Assaf Harofeh)

    Beer Yaakov, 7033001

  • Lady Davis Carmel Medical Center

    Haifa, 3436212

  • Shaare Zedek Medical Center

    Jerusalem, 9103102

  • Sourasky Medical Center

    Tel Aviv, 6093246

Other trials in Israel

Malaysia4 sites
  • Hospital Pulau Pinang-Pulau Pinang-21953

    George Town, 10990

  • Hospital Sultan Idris Shah Serdang

    Kajang, 43000

  • Institut Perubatan Respiratori

    Kuala Lumpur, 53000

  • Sarawak General Hospital

    Kuching, 93586

Other trials in Malaysia

Netherlands4 sites
  • Zuyderland Medisch Centrum

    HEERLENHeerlen, 6419

  • Leids Universitair Medisch Centrum (LUMC)

    Leiden, 2333

  • St. Antonius Ziekenhuis

    Nieuwegein, 3435 CM

  • Erasmus Medisch Centrum-ROTTERDAM-50697

    Rotterdam, 3015

Other trials in Netherlands

New Zealand4 sites
  • Waikato Hospital

    Hamilton, 3204

  • Greenlane Clinical Centre

    One Tree Hill, Auckland, 1051

  • Aotearoa Clinical Trials

    Papatoetoe, Auckland, 2025

  • Tauranga Hospital

    Tauranga South, 3112

Other trials in New Zealand

Croatia3 sites
  • University hospital center Zagreb

    Zagreb, 10000

  • University Hospital Dubrava

    Zagreb, 10000

  • Solmed Polyclinic

    Zagreb, 1000

Other trials in Croatia

Georgia3 sites
  • National Center for Tuberculosis and Lung Diseases, Tbilisi

    Tbilisi, 0101

  • LLC Diacor

    Tbilisi, 0159

  • LTD The First Medical Center

    Tbilisi, 0180

Other trials in Georgia

Norway3 sites
  • Haukeland Universitetssykehus

    Bergen, N-5021

  • Akershus Universitetssykehus HF

    Nordbyhagen, 1478

  • Oslo Universitetssykehus HF, Rikshospitalet

    Oslo, 0372

Other trials in Norway

Serbia3 sites
  • University Clinical Center of Serbia

    Belgrade, 11000

  • Institute for Pulmonary Diseases of Vojvodina

    Kamenitz, 21204

  • University Clinical Center Nis

    Niš, 18000

Other trials in Serbia

Chile2 sites
  • Instituto Nacional del Torax

    Providencia, Santiago de Chile, 7500000

  • Centro de Investigacion del Maule

    Talca, 3465586

Other trials in Chile

Denmark2 sites
  • Gentofte Hospital

    Hellerup, 2900

  • Odense University Hospital

    Odense C, 5000

Other trials in Denmark

Hungary2 sites
  • Koranyi National Institute For Pulmonolgy

    Budapest, 1121

  • University of Debrecen Clinical Centre

    Debrecen, 4032

Other trials in Hungary

India2 sites
  • Bhatia Hospital

    Mumbai, 400007

  • P.D. Hinduja National Hospital

    Mumbai, 400067

Other trials in India

Singapore2 sites
  • Singapore General Hospital

    Singapore, 169608

  • Tan Tock Seng Hospital

    Singapore, 308433

Other trials in Singapore

Sweden2 sites
  • Universitetssjukhuset Linköping

    Linköping, 581 85

  • Akademiska sjukhuset

    Uppsala, 75185

Other trials in Sweden

Czechia1 site
  • University Thomayer´s Hospital

    Prague, 140 59

Other trials in Czechia

Estonia1 site
  • North Estonia Medical Centre Foundation, Tallinn

    Tallinn, 13419

Other trials in Estonia

Ireland1 site
  • Connolly Hospital Blanchardstown

    Dublin, D15 X40D

Other trials in Ireland

Saudi Arabia1 site
  • King Abdullah International Medical Research Center

    Riyadh, 11481

Other trials in Saudi Arabia

Slovenia1 site
  • Hospital Golnik - Univ. Clinic of Pulmonary and Allergic Diseases

    Golnik, 4204

Other trials in Slovenia

South Africa1 site
  • Enhancing Care Foundation NPC

    Mount Edgecombe, 4301

Other trials in South Africa

Switzerland1 site
  • Universitätsspital Basel

    Basel, 4031

Other trials in Switzerland

About this study

Official title: An Open-label Extension Trial of the Long-term Safety and Efficacy of BI 1015550 Taken Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) (FIBRONEER™-ON)

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medicine called nerandomilast or BI 1015550.

The goal of this study is to find out how well people with pulmonary fibrosis tolerate long- term treatment with nerandomilast. The study also tests whether nerandomilast improves lung function and prolongs the time until symptoms get worse, participants need to go to the hospital, or die.

Read more

Every participant takes nerandomilast as tablets for up to 1 year and 10 months. The participants may also continue their regular treatment for pulmonary fibrosis during the study.

Participants visit their doctors regularly. During these visits, the doctors collect information on any health problems of the participants. Participants also regularly do lung function tests.

Being tested
Nerandomilast
Medical subject headings
Idiopathic Pulmonary Fibrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NerandomilastDrug

    Also called BI 1015550, JASCAYD®

    Nerandomilast

Study groups in NCT06238622
Study groupRoleWhat they receive
BI 1015550 treatment groupExperimentalNot described
Receives: Drug: Nerandomilast

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurrence of any adverse event over the course of the extension trial (yes/no) i.e. up until the follow-up/end of study visit planned at the latest at week 99

    Measured: Up to 99 weeks and 3 days

Secondary outcomes (8)
  1. Absolute change from baseline in Forced vital capacity (FVC) (mL) over time

    Measured: Up to 98 weeks

  2. Absolute change from baseline in % predicted in Forced vital capacity (FVC) over time

    Measured: Up to 98 weeks

  3. Time to absolute decline in FVC % predicted of >10% from baseline over the duration of the trial

    Measured: Up to 98 weeks

  4. Time to first acute Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis (IPF/PPF) exacerbation, first hospitalisation for respiratory cause, or death (whichever occurs first) over the duration of the trial

    Measured: Up to 98 weeks

  5. Time to first acute Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis (IPF/PPF) exacerbation or death over the duration of the trial

    Measured: Up to 98 weeks

  6. Time to hospitalisation for respiratory cause or death over the duration of the trial

    Measured: Up to 98 weeks

  7. Time to absolute decline in Forced vital capacity (FVC) % predicted of >10% from baseline or death over the duration of the trial

    Measured: Up to 98 weeks

  8. Time to relative decline in Forced vital capacity (FVC) % predicted of >10% from baseline or death over the duration of the trial

    Measured: Up to 98 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Feb 2024
  2. Study start26 Sep 2024
  3. Primary completion28 Apr 2027 (estimated)
  4. Study completion7 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
1,666 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06238622
Sponsor's protocol ID
1305-0031
Other IDs
2023-507353-15-00, 2023
Acronym
FIBRONEER™-ON
Status last verified
Oct 2026
First submitted
25 Jan 2024
Last updated
14 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
Individual data sharing
Yes: Once the criteria in section "Time Frame" are fulfilled, researchers can use the following link https://www.clinicalstudies.boehringer-ingelheim.com/msw/datasharing to request access to the clinical study documents regarding this study, and upon a signed "Document Sharing Agreement". Furthermore, researchers can request access to the clinical study data, for this and other listed studies, after the submission of a research proposal and according to the terms outlined in the website.

Publications

  • Wuyts WA, Richeldi L, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Martinez FJ, Valenzuela C, Wijsenbeek MS, Kanakapura M, James A, Weimann G, Drzewuski C, Coeck C, Maher TM. Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER-ON). BMC Pulm Med. 2025 Dec 4;26(1):10. doi: 10.1186/s12890-025-03973-7.

    PubMed 41345848

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in